Sodium Chloride Tablets Recalled for Potential Labeling Error
Aidapak Services is recalling 1,000 mg sodium chloride tablets that may be mislabeled as repaglinide. The error involves specific lots distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a labeling error that could lead to a temporary or medically reversible health consequence. No injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling 1,000 mg sodium chloride tablets that may have been mislabeled as repaglinide, 2 mg tablets. The recall is due to a labeling mixup where the sodium chloride product may bear the label for the diabetes medication repaglinide.
The affected product is identified by NDC 00527111610, with pedigree W003925 and an expiration date of 7/1/2014. The repaglinide product involved in the mixup has NDC 00169008481. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication labels for the specific NDC and pedigree numbers listed above. If the product matches the description, they should stop using it and contact their pharmacist or the recalling firm for instructions.
The recalled product
- Product
- SODIUM CHLORIDE, Tablet, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00527111610
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 1,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- SODIUM CHLORIDE
- Tablet
- 1000 mg has the following codes: Pedigree: W003925
- EXP: 7/1/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Magnesium Chloride Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereSodium Bicarbonate Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereWarfarin Sodium Tablets Recalled Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateWarfarin Sodium Tablets Recalled Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Calcium Citrate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Vitamin B Complex Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-22